US Stock MarketDetailed Quotes

BDRX Biodexa Pharmaceuticals

Watchlist
  • 1.280
  • -0.050-3.76%
Trading May 7 13:21 ET
3.28MMarket Cap-0.10P/E (TTM)

Biodexa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EPS
According to the latest financial report of Biodexa Pharmaceuticals, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: GBP

Quarterly

Loading...

FCF
Interested in knowing about Biodexa Pharmaceuticals's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: GBP

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Biodexa Pharmaceuticals shows that the company's current ratio is 1.75, indicating healthy liquidity.

Currency: GBP

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Biodexa Pharmaceuticals, the quick ratio is 0.47, indicating that the company can meet its short-term debt obligations.

Currency: GBP

Quarterly

Loading...

ROE
Want to learn more about the financial health of Biodexa Pharmaceuticals? The latest ROE figure is --, indicating that the company has stable profitability.

Currency: GBP

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Biodexa Pharmaceuticals, the total asset return on investment (ROA) is --.

Currency: GBP

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Biodexa Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at --.

Currency: GBP

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Biodexa Pharmaceuticals, the net profit margin is --, which is a good sign for its profitability.

Currency: GBP

Quarterly

Loading...

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 69.300
Sample Name
Sample Code
 5.945
Sample Name
Sample Code
 27.855
4
DexCom
DXCM
83.033
5
Constellation Brands
STZ
190.350
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 102.175
Sample Name
Sample Code
 188.960
Sample Name
Sample Code
 142.850
4
Netflix
NFLX
1158.445
5
Salesforce
CRM
278.085
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.1814
Sample Name
Sample Code
 1.715
Sample Name
Sample Code
 10.650
4
Argo Blockchain
ARBK
0.4064
5
Bitdeer Technologies
BTDR
11.205
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -